NCT00191763View on ClinicalTrials.gov

Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

December 31, 2005

Conditions
Carcinoma, Non-Small-Cell-Lung Cancer
Interventions
DRUG

Gemcitabine

DRUG

cisplatin

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Istanbul

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191763 - Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter